title: Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes.
abstract: Dendritic cell (DC) differentiation is abnormal in type 1 diabetes mellitus (T1DM). However, the nature of the relationship between this abnormality and disease pathogenesis is unknown. We studied the LPS response in monocytes and monocyte-derived DCs isolated from T1DM patients and from non-T1DM controls. In T1DM patients, late LPS-mediated nuclear DNA binding by RelA, p50, c-Rel, and RelB was impaired as compared with type 2 DM, rheumatoid arthritis, and healthy subjects, associated with impaired DC CD40 and MHC class I induction but normal cytokine production. In TIDM monocytes, RelA and RelB were constitutively activated, and the src homology 2 domain-containing protein tyrosine phosphatase (SHP-1), a negative regulator of NF-kappaB, was overexpressed. Addition of sodium stibogluconate, a SHP-1 inhibitor, to DCs differentiating from monocyte precursors restored their capacity to respond to LPS in approximately 60% of patients. The monocyte and DC NF-kappaB response to LPS is thus a novel phenotypic and likely pathogenetic marker for human T1DM. SHP-1 is at least one NF-kappaB regulatory mechanism which might be induced as a result of abnormal inflammatory signaling responses in T1DM monocytes.
authors.affiliation: Diamantina Institute for Cancer, Immunology, and Metabolic Medicine, University of Queensland, Department of Diabetes and Endocrinology, Princess Alexandria Hospital, Brisbane, Queensland, Australia.
authors.forename: Zia U A
authors.initials: ZU
authors.lastname: Mollah
authors.forename: Saparna
authors.initials: S
authors.lastname: Pai
authors.forename: Craig
authors.initials: C
authors.lastname: Moore
authors.forename: Brendan J
authors.initials: BJ
authors.lastname: O'Sullivan
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Harrison
authors.forename: Judy
authors.initials: J
authors.lastname: Peng
authors.forename: Karen
authors.initials: K
authors.lastname: Phillips
authors.forename: Johannes B
authors.initials: JB
authors.lastname: Prins
authors.forename: John
authors.initials: J
authors.lastname: Cardinal
authors.forename: Ranjeny
authors.initials: R
authors.lastname: Thomas
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D017951:Antigen Presentation / Q000276:immunology; D002454:Cell Differentiation / Q000276:immunology; D002478:Cells, Cultured; D002648:Child; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D020935:MAP Kinase Signaling System / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology*; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism
chemical_list: D016328:NF-kappa B